Logout
If you want to log out click in LogOut
AnyGenes® StaRT Reverse Transcription Kits are designed to support efficient first-strand cDNA synthesis from RNA samples before qPCR, qPCR arrays and targeted gene expression analysis.
Optimized for a broad RNA input range, from 5 ng to 2 µg RNA depending on the experimental setup, StaRT kits help researchers prepare high-quality cDNA for downstream transcriptomic workflows.
StaRT Reverse Transcription Kits are designed for researchers who need a robust reverse transcription step before qPCR, qPCR arrays, biomarker analysis or pathway-focused gene expression studies.
Supports reverse transcription workflows using 5 ng to 2 µg RNA, depending on sample quality, target abundance and downstream analysis.
Converts RNA into first-strand cDNA suitable for downstream real-time PCR and targeted gene expression workflows.
Designed for compatibility with standard qPCR assays, SignArrays® panels and targeted transcriptomic analysis.
Can support workflows involving RNA from cell lines, tissues, PBMCs, FFPE-derived samples or LCM samples.
Supports reverse transcription workflows involving selected AU-rich or GC-rich RNA regions, depending on assay design and sample quality.
Can be combined with SpeAmp® preamplification, validated qPCR primers, Master Mixes and SignArrays® panels.
Reverse transcription is a critical upstream step in qPCR-based gene expression analysis. The quality and consistency of cDNA synthesis can influence downstream Cq values, target detection and biological interpretation.
StaRT Reverse Transcription Kits are designed to support a streamlined workflow from RNA input to first-strand cDNA synthesis, followed by qPCR, qPCR arrays or targeted transcriptomic analysis.
RNA is prepared from the selected biological material and assessed according to the requirements of the downstream experiment.
StaRT reagents support the conversion of RNA into first-strand cDNA for downstream amplification.
The generated cDNA can be used for qPCR assays, SignArrays® qPCR arrays or selected gene expression workflows.
AnyGenes® has evaluated the StaRT Reverse Transcription workflow using qPCR quality control experiments designed to assess repeatability and amplification efficiency after cDNA synthesis.
These validation data support the use of StaRT kits in gene expression workflows, including qPCR assays, SignArrays® qPCR arrays and low-input transcriptomic applications.
StaRT Reverse Transcription Kits can be used in gene expression workflows involving routine samples as well as more challenging or precious biological material.
Supports routine reverse transcription workflows for qPCR-based gene expression studies.
Can be used with RNA extracted from tissue samples when RNA quality is suitable for downstream analysis.
Supports workflows involving immune cell samples and targeted transcript analysis.
Can support selected workflows involving fragmented or challenging RNA when assay design is adapted.
Suitable for workflows involving limited material from laser capture microdissection, depending on RNA quality and input.
Can be combined with downstream SpeAmp® preamplification when input material or target abundance is limited.
StaRT Reverse Transcription Kits support the upstream cDNA synthesis step in a wide range of qPCR and transcriptomic workflows.
Prepare cDNA for targeted quantification of selected genes, transcripts or biological signatures.
Generate first-strand cDNA for downstream real-time PCR assays and relative expression analysis.
Use StaRT-generated cDNA for pathway-focused qPCR array workflows and biomarker panels.
Support targeted qPCR validation of selected transcriptomic results after RNA-seq analysis.
Analyze selected gene signatures in research projects focused on biomarkers or signaling pathways.
Combine reverse transcription with SpeAmp® preamplification when starting material or target abundance is limited.
StaRT Reverse Transcription Kits can be integrated with complementary AnyGenes® qPCR solutions to support targeted gene expression analysis from RNA input to data interpretation.
Use SpeAmp® when input material is limited or when selected targets are weakly expressed.
Analyze selected genes using experimentally validated qPCR primer sets.
Profile selected signaling pathways or build personalized qPCR panels.
StaRT Reverse Transcription Kits are available in different reaction formats. Contact AnyGenes® for quotations, product information, distributor details or technical guidance.
| Catalog Reference | Number of Reactions | Price (before TAX) |
|---|---|---|
AnyGenes® can help you select the appropriate reverse transcription, preamplification, qPCR assay and SignArrays® workflow according to your RNA input, sample type, target genes and research objectives.
Whether your project involves gene expression analysis, biomarker research, RNA-seq validation, qPCR arrays or low-input samples, our team can help you define a targeted qPCR strategy.
Reverse transcription kits are used to convert RNA into complementary DNA, or cDNA, before downstream qPCR, qPCR array or gene expression analysis.
StaRT Reverse Transcription Kits can support workflows using 5 ng to 2 µg RNA, depending on sample quality, input availability and downstream qPCR requirements.
Yes. StaRT-generated cDNA can be used in adapted qPCR array workflows, including AnyGenes® SignArrays® panels for pathway-focused gene expression analysis.
StaRT kits can support selected workflows involving FFPE-derived RNA or LCM samples, provided that RNA quality, input amount and assay design are adapted to the project.
Yes. StaRT reverse transcription can be followed by SpeAmp® cDNA preamplification when input material is limited or selected targets are weakly expressed.
Yes. AnyGenes® can help adapt the workflow according to RNA input, sample type, target genes, preamplification needs and downstream qPCR analysis.
Visit the AnyGenes® Help & FAQ section for detailed information about our products, services, ordering process and technical support.
Visit Help & FAQ